share_log
Reuters ·  Jan 26 10:40
Livzon Says Nmpa Accepts Market Authorization Application of Co's Drug "Recombinant Human Follitropin Alfa Solution for Injection"
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Write a comment